Breaking News Instant updates and real-time market news.

RDUS

Radius Health

$47.40

-0.95 (-1.96%)

07:09
07/17/17
07/17
07:09
07/17/17
07:09

Radius Health appoints Jesper Hoiland as CEO

Radius Health (RDUS) announced that Jesper Hoiland has been appointed President and CEO of the company. Prior to joining Radius, Hoiland served as president of Novo Nordisk Inc. USA (NVO).

  • 03

    Aug

RDUS Radius Health
$47.40

-0.95 (-1.96%)

05/22/17
ADAM
05/22/17
NO CHANGE
Target $85
ADAM
Buy
CV events 'may kill' Amgen's romosozumab development, says Canaccord
Canaccord analyst John Newman said Amgen (AMGN) and partner UCB's report of a higher rate of cardiovascular Serious Adverse Events for romosozumab in the Phase 3 ARCH study in osteoporosis suggests a much lower chance of FDA approval for the drug and may "kill" romosozumab's development. He notes that Merck's (MRK) cathepsin-K inhibitor was previously discontinued due to increased risk of atrial fibrillation and stroke. In addition to the safety signals, Newman points out that romosozumab was worse than Radius' (RDUS) Tymlos for non-vertebral fracture and for vertebral fracture, suggesting Radius' drug also has much better efficacy, said the analyst, who keeps a Buy rating and $85 price target on Radius Health shares, which are up $4.47, or 12.8%, to $39.40 in pre-market trading.
05/22/17
LEER
05/22/17
NO CHANGE
Target $159
LEER
Market Perform
Leerink sees only 50/50 chance of Amgen's Evenity hitting market
After Amgen (AMGN) and UCB reported an "imbalance of positively adjudicated serious cardiovascular adverse events" in its Phase 3 study of Evenity, Leerink analyst Geoffrey Porges believes the product now has only a 50/50 probability of coming to market at all. The analyst lowered his price target for Amgen shares to $159 from $160 and keeps a Market Perform rating on the name. Radius Health (RDUS), which has a drug that would compete with Evenity, is trading up 16% to $40.58 in the premarket.
05/22/17
JPMS
05/22/17
NO CHANGE
Target $74
JPMS
Overweight
Amgen data a 'clear positive' for Radius Health, says JPMorgan
JPMorgan analyst Jessica Fye believes the imbalance in observed cardiovascular serious adverse events reported by Amgen (AMGN) and UCB over the weekend for Evenity is a "clear positive" for Radius Health (RDUS). The FDA will now add results from the Phase 3 ARCH study to the regulatory review, and as a result Amgen does not expect U.S. approval for Evenity in 2017, Fye tells investors in a research note. The update is a "clear positive" for Radius Health, who has Tymlos already approved with a clean clinical safety profile, the analyst contends. She continues to believe Tymlos is well positioned for a successful launch into the large market opportunity of postmenopausal women with osteoporosis at high risk of fracture. Fye has an Overweight rating on Radius with a $74 price target. The stock in premarket trading is up 13%, or $4.62, to $39.55.
05/02/17
COWN
05/02/17
DOWNGRADE
COWN
Market Perform
Radius Health downgraded to Market Perform from Outperform at Cowen
Cowen analyst Chris Shibutani downgraded Radius Health to Market Perform due to fewer near-term drivers following a proprietary expert survey regarding the outlook for Tymlos. The analyst said Tymolos has attractive features versus Forteo but differentiation is relatively limited and physicians expressed concerns over pricing and reimbursement. Further, Amgen's romosozumab's potential approval near-term and the potential entry of Forteo generic/biosimilar long-term are potential competitive threats.

TODAY'S FREE FLY STORIES

LUV

Southwest

$57.67

-1.85 (-3.11%)

12:44
07/27/17
07/27
12:44
07/27/17
12:44
Hot Stocks
Southwest sees Q3 fuel price per gallon $1.95-$2.00 »

Says achieved milestone…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

NVO

Novo Nordisk

$41.40

-0.59 (-1.41%)

12:44
07/27/17
07/27
12:44
07/27/17
12:44
Hot Stocks
Novo Nordisk says Victoza approved in EU for expanded indication »

Novo Nordisk says the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLVS

Clovis

$87.43

1.46 (1.70%)

, TSRO

Tesaro

$130.06

1.11 (0.86%)

12:41
07/27/17
07/27
12:41
07/27/17
12:41
Recommendations
Clovis, Tesaro, Merck, AstraZeneca analyst commentary  »

PARP deals may make…

CLVS

Clovis

$87.43

1.46 (1.70%)

TSRO

Tesaro

$130.06

1.11 (0.86%)

MRK

Merck

$64.43

2.63 (4.26%)

AZN

AstraZeneca

$28.99

-4.95 (-14.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 28

    Jul

  • 01

    Aug

  • 02

    Aug

  • 08

    Aug

  • 28

    Aug

  • 22

    Sep

FB

Facebook

$165.61

0.33 (0.20%)

, VZ

Verizon

$47.37

2.965 (6.68%)

12:38
07/27/17
07/27
12:38
07/27/17
12:38
General news
On The Fly: Top stock stories at midday »

Stocks opened higher…

FB

Facebook

$165.61

0.33 (0.20%)

VZ

Verizon

$47.37

2.965 (6.68%)

AZN

AstraZeneca

$28.99

-4.9508 (-14.59%)

GNC

GNC Holdings

$10.63

1.26 (13.45%)

BUD

AB InBev

$122.76

7.05 (6.09%)

TSCO

Tractor Supply

$53.40

-0.13 (-0.24%)

CYH

Community Health

$7.14

-1.3225 (-15.63%)

TWTR

Twitter

$17.06

-2.5508 (-13.01%)

BWLD

Buffalo Wild Wings

$122.65

-1.05 (-0.85%)

WHR

Whirlpool

$176.45

-13.74 (-7.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 02

    Aug

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

  • 16

    Aug

  • 16

    Aug

  • 18

    Aug

  • 23

    Aug

  • 11

    Sep

  • 13

    Sep

  • 19

    Sep

LUV

Southwest

$57.56

-1.96 (-3.29%)

12:37
07/27/17
07/27
12:37
07/27/17
12:37
Hot Stocks
Southwest sees 'modest' capacity growth in Q4 in 1%-2% range »

Says Q3 outlook in line…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

LUV

Southwest

$57.60

-1.925 (-3.23%)

12:36
07/27/17
07/27
12:36
07/27/17
12:36
Hot Stocks
Southwest sees Q4 unit costs in line with year-ago levels »

The company expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

LUV

Southwest

$57.60

-1.925 (-3.23%)

12:36
07/27/17
07/27
12:36
07/27/17
12:36
Hot Stocks
Southwest sees Q3 unit costs ex-items up 2%-3% y/y »

Based on current cost…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

AAPL

Apple

$153.46

0.72 (0.47%)

12:34
07/27/17
07/27
12:34
07/27/17
12:34
Periodicals
Apple confirms discontinuation of iPod nano, shuffle, The Verge reports »

Apple is discontinuing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

HOG

Harley-Davidson

$49.96

1.32 (2.71%)

12:30
07/27/17
07/27
12:30
07/27/17
12:30
Options
Heavy call activity in Harley Davidson as shares rally »

Heavy call activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

12:30
07/27/17
07/27
12:30
07/27/17
12:30
General news
Atlanta Fed's final Q2 GDPNow estimate was boosted to 2.8% »

Atlanta Fed's final…

VBIV

VBI Vaccines

$4.61

-0.03 (-0.65%)

12:25
07/27/17
07/27
12:25
07/27/17
12:25
Conference/Events
VBI Vaccines to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 26

    Sep

DAL

Delta Air Lines

$50.74

-0.395 (-0.77%)

, AFLYY

Air France-KLM

$14.14

0.18 (1.29%)

12:22
07/27/17
07/27
12:22
07/27/17
12:22
Hot Stocks
Delta Air Lines to acquire 10% equity stake in Air France-KLM for EUR375M »

Delta Air Lines (DAL)…

DAL

Delta Air Lines

$50.74

-0.395 (-0.77%)

AFLYY

Air France-KLM

$14.14

0.18 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GG

Goldcorp

$12.88

-0.91 (-6.60%)

12:20
07/27/17
07/27
12:20
07/27/17
12:20
Options
Repeat activity in GoldCorp after earnings »

Repeat activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

12:20
07/27/17
07/27
12:20
07/27/17
12:20
General news
Treasury Option Action: heavy put activity »

Treasury Option Action:…

$NSD

NASDAQ Market Internals

12:17
07/27/17
07/27
12:17
07/27/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
07/27/17
07/27
12:16
07/27/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$78.91

-0.4533 (-0.57%)

12:15
07/27/17
07/27
12:15
07/27/17
12:15
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

TDOC

Teladoc

$31.78

-2.575 (-7.50%)

, AMZN

Amazon.com

$1,052.80

12.93 (1.24%)

12:11
07/27/17
07/27
12:11
07/27/17
12:11
Recommendations
Teladoc, Amazon.com analyst commentary  »

Teladoc selloff on Amazon…

TDOC

Teladoc

$31.78

-2.575 (-7.50%)

AMZN

Amazon.com

$1,052.80

12.93 (1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 02

    Aug

  • 16

    Aug

  • 18

    Aug

SBUX

Starbucks

$57.94

-0.61 (-1.04%)

12:11
07/27/17
07/27
12:11
07/27/17
12:11
Technical Analysis
Technical Earnings Preview: Starbucks in consolidation phase before news »

The stock has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 23

    Aug

AAPL

Apple

$153.46

0.72 (0.47%)

12:06
07/27/17
07/27
12:06
07/27/17
12:06
Periodicals
Breaking Periodicals news story on Apple »

Apple to discontinue iPod…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

NTES

NetEase

$312.15

3.26 (1.06%)

12:05
07/27/17
07/27
12:05
07/27/17
12:05
Options
NetEase call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

WABC

Westamerica

$54.57

-1.82 (-3.23%)

12:04
07/27/17
07/27
12:04
07/27/17
12:04
Hot Stocks
Westamerica announces announces stock repurchase plan »

Westamerica…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:00
07/27/17
07/27
12:00
07/27/17
12:00
General news
Treasury's $20 B 14-day cash management bill saw pretty good demand »

Treasury's $20 B…

INTC

Intel

$34.75

0.08 (0.23%)

12:00
07/27/17
07/27
12:00
07/27/17
12:00
Periodicals
Intel sells four offices buildings, development center in Alameda, SVBJ says »

Intel has sold four…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 10

    Aug

  • 15

    Aug

  • 28

    Aug

HOG

Harley-Davidson

$49.03

0.39 (0.80%)

, TSLA

Tesla

$343.85

4.25 (1.25%)

11:58
07/27/17
07/27
11:58
07/27/17
11:58
Hot Stocks
Harley-Davidson jumps amid chatter of Tesla partnership »

The move higher in shares…

HOG

Harley-Davidson

$49.03

0.39 (0.80%)

TSLA

Tesla

$343.85

4.25 (1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 08

    Aug

  • 02

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.